Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801488 · ClinicalTrials.gov registry record
Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT01801488: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.
NCT01801488 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01801488 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Test single nucleotide polymorphisms (SNP's) in ruptured and unruptured aneurysm tissue to identify a genetic difference between the two types of aneurysms; and to test SNP's in arteriovenous malformation tissue to identify a genetic link.
Primary Outcome
The samples will be frozen after collection and then analyzed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-11 |
Why NCT01801488 stopped before completion
NCT01801488 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01801488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01801488 about?
NCT01801488 is a clinical study titled "Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm". Test single nucleotide polymorphisms (SNP's) in ruptured and unruptured aneurysm tissue to identify a genetic difference between the two types of aneurysms; and to test SNP's in arteriovenous malformation tissue to identify a genetic link.
What is the current status of trial NCT01801488?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2011-11.
Who is sponsoring clinical trial NCT01801488?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia